INSITRO Trademark

Trademark Overview


On Wednesday, December 18, 2024, a trademark application was filed for INSITRO with the United States Patent and Trademark Office. The USPTO has given the INSITRO trademark a serial number of 98910353. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Monday, July 28, 2025. This trademark is owned by Insitro, Inc.. The INSITRO trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Laboratory automation systems comprising apparatus for automated cell and molecule screening and software controlling the apparatus; Artificial intelligence (AI) and machine learning (ML) platforms, namely, recorded software platforms for experimental data generation for scientific and laboratory applications for scientific and medical research, drug discovery and drug development; digital health solutions, namely, downloadable software for integrating data-driven medical insights.

Pharmaceutical preparations and substances for human and veterinary use for the treatment and prevention of diseases, namely, human metabolic diseases, human neurological diseases, human ophthalmological diseases, and human genetic diseases.

Chemical and biological reagents for scientific research, drug discovery, and drug development; laboratory chemicals and solutions for research purposes, excluding those for medical use, namely, reagents supporting artificial intelligence-driven workflows and machine learning applications

Personalized medicine services, including namely, making recommendations for medical diagnostic tests and therapeutic recommendations to patients; healthcare services utilizing artificial intelligence for disease prediction, patient stratification, and management; medical analysis services for diagnostic and treatment purposes of patients; healthcare services; medical treatment services for diseases; healthcare advisory services; pharmaceutical advice; medical clinic services; medical advice for individuals with diseases; provision of medicine in the field of diseases, namely, developing treatments for unmet medical needs

Scientific and technological research and development services in the fields of drug discovery, pharmaceutical development, and biotechnology; Platform as a Service featuring artificial intelligence (AI) and machine learning (ML) software platforms for drug discovery, pharmaceutical development, and biotechnology for scientific and medical research; Development of computer software, for drug discovery, genomics, and data analysis; laboratory research services in the field of pharmaceuticals, using automation, high-throughput experimentation, and data modeling software as a service (SaaS) featuring software for AI-powered drug discovery, predictive modeling, and biological data analysis; consulting services in computational biology and AI-driven drug discovery; Medical research services and consulting services in the field of medical research; drug discovery and development support services from a medical perspective, namely, pharmaceutical drug development services; providing medical i...
insitro

General Information


Serial Number98910353
Word MarkINSITRO
Filing DateWednesday, December 18, 2024
Status645 - FINAL REFUSAL - MAILED
Status DateMonday, July 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the word "insitro" in lower case, stylized font in which the dot over both of the letters "i" is a hexagon, and the first letter "i" is encircled by two strands of a helix comprised of dots and squares.
Goods and ServicesLaboratory automation systems comprising apparatus for automated cell and molecule screening and software controlling the apparatus; Artificial intelligence (AI) and machine learning (ML) platforms, namely, recorded software platforms for experimental data generation for scientific and laboratory applications for scientific and medical research, drug discovery and drug development; digital health solutions, namely, downloadable software for integrating data-driven medical insights.
Goods and ServicesPharmaceutical preparations and substances for human and veterinary use for the treatment and prevention of diseases, namely, human metabolic diseases, human neurological diseases, human ophthalmological diseases, and human genetic diseases.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesChemical and biological reagents for scientific research, drug discovery, and drug development; laboratory chemicals and solutions for research purposes, excluding those for medical use, namely, reagents supporting artificial intelligence-driven workflows and machine learning applications
Goods and ServicesPersonalized medicine services, including namely, making recommendations for medical diagnostic tests and therapeutic recommendations to patients; healthcare services utilizing artificial intelligence for disease prediction, patient stratification, and management; medical analysis services for diagnostic and treatment purposes of patients; healthcare services; medical treatment services for diseases; healthcare advisory services; pharmaceutical advice; medical clinic services; medical advice for individuals with diseases; provision of medicine in the field of diseases, namely, developing treatments for unmet medical needs
Goods and ServicesScientific and technological research and development services in the fields of drug discovery, pharmaceutical development, and biotechnology; Platform as a Service featuring artificial intelligence (AI) and machine learning (ML) software platforms for drug discovery, pharmaceutical development, and biotechnology for scientific and medical research; Development of computer software, for drug discovery, genomics, and data analysis; laboratory research services in the field of pharmaceuticals, using automation, high-throughput experimentation, and data modeling software as a service (SaaS) featuring software for AI-powered drug discovery, predictive modeling, and biological data analysis; consulting services in computational biology and AI-driven drug discovery; Medical research services and consulting services in the field of medical research; drug discovery and development support services from a medical perspective, namely, pharmaceutical drug development services; providing medical information and consultancy, namely, providing information and consulting in the field of medical research, related to therapeutic research and development; provision of medicine in the field of diseases, namely, developing treatments for unmet medical needs.

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, December 18, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 18, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateWednesday, December 18, 2024
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 18, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 18, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameInsitro, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Wednesday, December 18, 2024NEW APPLICATION ENTERED
Sunday, January 26, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Sunday, January 26, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 27, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 27, 2025NON-FINAL ACTION E-MAILED
Monday, January 27, 2025NON-FINAL ACTION WRITTEN
Monday, January 27, 2025ASSIGNED TO EXAMINER
Thursday, July 24, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 28, 2025FINAL REFUSAL E-MAILED
Monday, July 28, 2025FINAL REFUSAL WRITTEN
Monday, July 28, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, July 24, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 22, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, April 22, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, July 24, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE